Gaurav Shrivastava

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Venous Thromboembolism

Respiratory Syndrome Coronavirus

Immune Response

Top Venues

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Noe Juvenal Mendoza-Ramírez, Julio García-Cordero, Gaurav Shrivastava, Leticia Cedillo-Barrón
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein. Journal of immunology research 2024 (2024)
Noe Juvenal Mendoza-Ramírez, Julio García-Cordero, Gaurav Shrivastava, Leticia Cedillo-Barrón
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein. Journal of immunology research 2024 (2024)
Noe Juvenal Mendoza-Ramírez, Julio García-Cordero, Gaurav Shrivastava, Leticia Cedillo-Barrón
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein. Journal of immunology research 2024 (2024)
Noe Juvenal Mendoza-Ramírez, Julio García-Cordero, Gaurav Shrivastava, Leticia Cedillo-Barrón
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein. Journal of immunology research 2024 (2024)
Gaurav Shrivastava, Paola Carolina Valenzuela-Leon, Andrezza Campos Chagas, Olivia Kern, Karina Botello, Yixiang Zhang, Inés Martin-Martin, Markus Berger Oliveira, Lucas Tirloni, Eric Calvo
Alboserpin, the Main Salivary Anticoagulant from the Disease Vector Aedes albopictus , Displays Anti-FXa-PAR Signaling In Vitro and In Vivo. ImmunoHorizons 6 (6) (2022)